Alberto La Mantia

Alberto La Mantia

Auto-generated profile, based on publicly available information

Alberto La Mantia

Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Ophthalmology
Verified
Journal Article
Closed access
SMStavros N. Moysidis
Stavros N. Moysidis
NKNicole Koulisis
Nicole Koulisis
SASean D. Adrean
Sean D. Adrean
SCSteve Charles
Steve Charles
NCNaren Chetty
Naren Chetty
TMTamer H. Mahmoud
Tamer H. Mahmoud

7 September 2022 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
AMAlberto La Mantia
Alberto La Mantia
CMCarlos Mateo
Carlos Mateo
Purpose: To demonstrate a modified technique of perfluorocarbon liquid (PFCL)/internal limiting membrane (ILM) interface staining in patients affected by macular hole retinal detachment (MHRD) in the setting of high myopia. Methods: Two-surgeon retrospective case series and review of surgical videos with step-by-step technique analysis. Results: Our modified technique was proficiently employed to treat 9 highly myopic patients affected by MHRD. Successful staining and peeling of the ILM with the creation of an inverted flap was achieved in all cases. A limited number of dye injections required to stain the ILM was noted. No subretinal dye migration or other intra- and postoperative complications were recorded. Conclusion: Modified PFCL/ILM interface staining is a surgically efficient technique potentially reducing the risk of iatrogenic damage, including the toxicity of vital dyes to the retinal pigment epithelium (RPE) in myopic MHRD.

15 October 2024 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
ECEnea Chisci
Enea Chisci
GTGiulia Torregrossa
Giulia Torregrossa
STSalvatore Torregrossa
Salvatore Torregrossa
AMAlberto La Mantia
Alberto La Mantia
Purpose: To present a modified surgical technique for implantation of the sutureless scleral-fixated hydrophilic intraocular lens (FIL SSF). Methods: Single surgeon retrospective case series and review of surgical videos with step-by-step technique analysis. Uncorrected and best corrected visual acuity (UCVA and BCVA), refractive error (spherical equivalent), full clinical examination with intraocular pressure (IOP) measurement, endothelial cell density on corneal specular microscopy and macular optical coherence tomography (OCT) were recorded at baseline, 1, 4 and 8 weeks postoperatively. Results: The FIL SSF IOLs were successfully implanted using the so-called “full reverse” technique, having the lens loaded in the injector in an upside-down fashion, as opposed to IOL technical specifications. In all cases, the FIL SSF IOL was properly placed in the ciliary sulcus, well-centered and without signs of tilt. Follow up figures at 2 months are consistent with published data, confirming the potential benefits of the new implantation technique. Conclusion: In our preliminary experience, the “full reverse” technique of the FIL SSF IOL has proven effective in preventing incorrect IOL orientation in 100% of cases. However, larger prospective controlled studies and longer follow up are required to either support or disprove our results.